REQUEST A DEMO
Total
USD $0.00
Search more companies

Rd Badania Kliniczne Sp. z o.o. (Poland)

Main Activities: Periodical Publishers
Full name: Rd Badania Kliniczne Sp. z o.o. Profile Updated: May 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Rd Badania Kliniczne Sp. z o.o. is an enterprise in Poland, with the main office in Warsaw. The enterprise operates in the Periodical Publishers industry. It was established on January 08, 2018. From the latest financial highlights, Rd Badania Kliniczne Sp. z o.o. reported a net sales revenue drop of 29.28% in 2023. A growth of 19.44% was recorded in its total assets. The net profit margin of Rd Badania Kliniczne Sp. z o.o. decreased by 21.64% in 2023.

Headquarters
Ul. Jana Iii Sobieskiego 66/47
Warsaw; Mazowieckie; Postal Code: 02-930

Contact Details: Purchase the Rd Badania Kliniczne Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Rd Badania Kliniczne Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Rd Badania Kliniczne Sp. z o.o. report to view the information.
Incorporation Date:
January 08, 2018
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Management Board Member
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Rd Badania Kliniczne Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
-29.28%
Total operating revenue
-29.29%
Operating profit (EBIT)
-66.74%
Net Profit (Loss) for the Period
-67.49%
Total assets
19.44%
Total equity
27.89%
Operating Profit Margin (ROS)
-23.53%
Net Profit Margin
-21.64%
Return on Equity (ROE)
-64%
Quick Ratio
1.81%
Cash Ratio
1.64%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?